Skip to content

Sepsis in India Prevalence Study (SIP Study)

Sepsis in India Prevalence Study: A single-day, prospective, observational, multicentre, nation-wide point-prevalence study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12619000012178
Acronym
SIP
Enrollment
666
Registered
2019-01-08
Start date
2019-05-29
Completion date
2019-07-17
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Point prevalence study in India to identify sepsis prevalence in Indian ICUs In 2017, The World Health Organization recognised sepsis as a global health priority. The true disease burden of sepsis remains unknown as the current estimates of disease burden are largely based on the data from high income countries (HIC). Even though the majority of the global population lives in lower/middle income countries (LMICs), there is a scarcity of sepsis epidemiology data from LMICs. In countries such as India, 1 in 3 people who develop sepsis die. Many of these deaths are preventable but the epidemiology of sepsis is poorly understood. This problem is further compounded by a very high level of antimicrobial resistance. This study will provide up-to-date knowledge of the epidemiology and outcomes of sepsis, antibiotic use and antimicrobial resistance in intensive care units (ICUs) in Indian hospitals.

Interventions

A single-day, prospective, observational, multicentre, nation-wide point-prevalence study of sepsis in Indian Intensive Care Units. Data will be collected over a designated 24-hour study day, starting 08:00 am on the study day till 08:00 am on the following day. For ICUs participating in this study, a questionnaire to collect hospital- and ICU-level data will be administered along with individual patient data.Data analysis will be guided by a statistical analysis plan, which will be developed b

A single-day, prospective, observational, multicentre, nation-wide point-prevalence study of sepsis in Indian Intensive Care Units. Data will be collected over a designated 24-hour study day, starting 08:00 am on the study day till 08:00 am on the following day. For ICUs participating in this study, a questionnaire to collect hospital- and ICU-level data will be administered along with individual patient data.Data analysis will be guided by a statistical analysis plan, which will be developed before the database is locked. Data analysis will be undertaken at the George Institute for Global Health by statisticians using a statistical software package. To address the primary objectives descriptive statistics will be used including univariate comparisons.

Sponsors

The George Institute for Global Health
Lead SponsorOther

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All adult patients (18 years or older) present in the ICU at the start of the study day or admitted during the 24-hour study period will be included in the study sample

Exclusion criteria

NONE

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026